Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ABOS Acumen Pharmaceuticals
- 2.030
- -0.040-1.93%
Close Dec 13 16:00 ET
- 2.030
- 0.0000.00%
Post 20:01 ET
121.96MMarket Cap-1.47P/E (TTM)
2.090High1.945Low336.98KVolume2.090Open2.070Pre Close677.34KTurnover1.04%Turnover RatioLossP/E (Static)60.08MShares5.09052wk High0.56P/B65.81MFloat Cap1.94552wk Low--Dividend TTM32.42MShs Float26.980Historical High--Div YieldTTM7.01%Amplitude1.810Historical Low2.010Avg Price1Lot Size
About Acumen Pharmaceuticals Company
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Company Profile
SymbolABOS
Company NameAcumen Pharmaceuticals
Listing DateJul 1, 2021
Issue Price16.00
Founded1996
CEOMr. Daniel O'Connell
MarketNASDAQ
Employees52
Fiscal Year Ends12-31
Address427 Park Street
CityCharlottesville
ProvinceVirginia
CountryUnited States of America
Zip Code22902
Phone1-434-297-1000
Websitehttp://www.acumenpharm.com
Company Executives
- Name
- Position
- Salary
- Daniel O'Connell
- Director and Chief Executive Officer
- 3.93M
- Dr. Jim Doherty, PhD
- President and Chief Development Officer
- --
- James J. Doherty
- President and Chief Development Officer
- --
- Russell Barton, M.S.
- Chief Operating Officer
- --
- Derek M. Meisner
- Chief Legal Officer
- 1.48M
- Dr. Eric Siemers, M.D.
- Chief Medical Officer
- --
- William Matthew Zuga
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 1.61M
- Sean Stalfort
- Chairman of the Board
- 173.52K
- Dr. Kimberlee Cobleigh Drapkin, PhD
- Independent Director
- 152.27K
- Dr. Laura Stoppel, PhD
- Independent Director
- 147.52K
- Dr. Jeffrey L. Ives, PhD
- Independent Director
- 141.02K
- Dr. Nathan B. Fountain, M.D.
- Independent Director
- 135.02K
- Dr. Derrell D. Porter, M.D.
- Independent Director
- 339.81K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.